UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Potential for vitamin D receptor agonists in the treatment of cardiovascular disease

British journal of pharmacology, 2009-09, Vol.158 (2), p.395-412

Wu‐Wong, JR

2009

Volltextzugriff (PDF)

Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption

British journal of cancer, 2000-08, Vol.83 (3), p.360-365

2000

Volltextzugriff (PDF)

Vitamin D receptor: A highly versatile nuclear receptor

Kidney international, 2007-08, Vol.72 (3), p.237-239

Wu-Wong, J.R.

2007

Volltextzugriff (PDF)

Statins do not directly activate vitamin D receptor

Journal of thrombosis and haemostasis, 2007-02, Vol.5 (2), p.415-416

2007

Volltextzugriff (PDF)

Expression of endothelin 1 and endothelin a receptor in ovarian carcinoma : Evidence for an autocrine role in tumor growth

Cancer research (Chicago, Ill.), 1999-02, Vol.59 (3), p.720-727

1999

Volltextzugriff (PDF)

A Causal Role for Endothelin-1 in the Pathogenesis of Osteoblastic Bone Metastases

Proceedings of the National Academy of Sciences - PNAS, 2003-09, Vol.100 (19), p.10954-10959

2003

Volltextzugriff (PDF)

Endothelin-1-evoked arachidonic acid release: a Ca(2+)-dependent pathway

American Journal of Physiology: Cell Physiology, 1996-09, Vol.271 (3), p.C869-C877

1996

Volltextzugriff (PDF)

Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist

The Journal of pharmacology and experimental therapeutics, 1996-02, Vol.276 (2), p.473

1996

Volltextzugriff (PDF)

Endothelin receptor in human astrocytoma U373MG cells: binding, dissociation, receptor internalization

The Journal of pharmacology and experimental therapeutics, 1995-07, Vol.274 (1), p.499

1995

Volltextzugriff (PDF)

Endothelin‐converting enzymes

The FASEB journal, 1992-06, Vol.6 (9), p.2653-2659

1992

Volltextzugriff (PDF)

Endothelin receptors in human smooth muscle cells: antagonist potency differs on agonist-evoked responses

American Journal of Physiology: Cell Physiology, 1994-11, Vol.267 (5), p.C1185-C1195

1994

Volltextzugriff (PDF)

2,4-Diarylpyrrolidine-3-carboxylic AcidsPotent ETA Selective Endothelin Receptor Antagonists. 1. Discovery of A-127722

Journal of medicinal chemistry, 1996-03, Vol.39 (5), p.1039-1048

1996

Volltextzugriff (PDF)

New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade

Urology (Ridgewood, N.J.), 1999-05, Vol.53 (5), p.1063-1069

1999

Volltextzugriff (PDF)

Phosphoramidon modulates the number of endothelin receptors in cultured Swiss 3T3 fibroblasts

Molecular pharmacology, 1993-08, Vol.44 (2), p.422-429

1993

Volltextzugriff (PDF)

Internalization of Type-A Endothelin Receptor

Journal of cardiovascular pharmacology, 2000, Vol.36 Suppl 1 (5 Suppl 1), p.S61-S65

2000

Volltextzugriff (PDF)

Identification and characterization of type A endothelin receptors in MMQ cells

Molecular pharmacology, 1993-08, Vol.44 (2), p.285-291

1993

Volltextzugriff (PDF)

Endothelial dysfunction and chronic kidney disease: treatment options

Current opinion in investigational drugs (London, England : 2000), 2008-09, Vol.9 (9), p.970

Wu-Wong, J Ruth

2008

Volltextzugriff (PDF)

A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors

Cancer research (Chicago, Ill.), 2001-07, Vol.61 (14), p.5480-5485

2001

Volltextzugriff (PDF)

Endothelin attenuates apoptosis in human smooth muscle cells

Biochemical journal, 1997-12, Vol.328 ( Pt 3) (3), p.733-737

1997

Volltextzugriff (PDF)

SV40 virus transformation down-regulates endothelin receptor

Biochimica et biophysica acta, 1999-05, Vol.1450 (1), p.35-44

1999

Volltextzugriff (PDF)

Dissociation Characteristics of Endothelin Receptor Agonists and Antagonists in Cloned Human Type-B Endothelin Receptor

Endothelium (New York, N.Y.), 1997, Vol.5 (3), p.179-189

1997

Volltextzugriff (PDF)

Pyrrolidine-3-carboxylic Acids as Endothelin Antagonists. 3. Discovery of a Potent, 2-Nonaryl, Highly Selective ETA Antagonist (A-216546)

Journal of medicinal chemistry, 1998-08, Vol.41 (17), p.3261-3275

1998

Volltextzugriff (PDF)

Endothelin Stimulates Glucose Uptake and GLUT4 Translocation via Activation of Endothelin ETA Receptor in 3T3-L1 Adipocytes

The Journal of biological chemistry, 1999-03, Vol.274 (12), p.8103-8110

1999

Volltextzugriff (PDF)

Are vitamin D receptor activators useful for the treatment of thrombosis?

Current opinion in investigational drugs (London, England : 2000), 2009-09, Vol.10 (9), p.919

Wu-Wong, J Ruth

2009

Volltextzugriff (PDF)

New Antimitotic Agents with Activity in Multi-Drug-Resistant Cell Lines and in Vivo Efficacy in Murine Tumor Models

Journal of medicinal chemistry, 2001-12, Vol.44 (25), p.4416-4430

2001

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(70)

Publikationsform

Sprache

Englisch
(88)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Potential for vitamin D receptor agonists in the treatment of cardiovascular disease

Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption

Vitamin D receptor: A highly versatile nuclear receptor

Statins do not directly activate vitamin D receptor

Expression of endothelin 1 and endothelin a receptor in ovarian carcinoma : Evidence for an autocrine role in tumor growth

A Causal Role for Endothelin-1 in the Pathogenesis of Osteoblastic Bone Metastases

Endothelin-1-evoked arachidonic acid release: a Ca(2+)-dependent pathway

Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist

Endothelin receptor in human astrocytoma U373MG cells: binding, dissociation, receptor internalization

Endothelin‐converting enzymes

Endothelin receptors in human smooth muscle cells: antagonist potency differs on agonist-evoked responses

2,4-Diarylpyrrolidine-3-carboxylic AcidsPotent ETA Selective Endothelin Receptor Antagonists. 1. Discovery of A-127722

New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade

Phosphoramidon modulates the number of endothelin receptors in cultured Swiss 3T3 fibroblasts

Internalization of Type-A Endothelin Receptor

Identification and characterization of type A endothelin receptors in MMQ cells

Endothelial dysfunction and chronic kidney disease: treatment options

A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors

Endothelin attenuates apoptosis in human smooth muscle cells

SV40 virus transformation down-regulates endothelin receptor

Dissociation Characteristics of Endothelin Receptor Agonists and Antagonists in Cloned Human Type-B Endothelin Receptor

Pyrrolidine-3-carboxylic Acids as Endothelin Antagonists. 3. Discovery of a Potent, 2-Nonaryl, Highly Selective ETA Antagonist (A-216546)

Endothelin Stimulates Glucose Uptake and GLUT4 Translocation via Activation of Endothelin ETA Receptor in 3T3-L1 Adipocytes

Are vitamin D receptor activators useful for the treatment of thrombosis?

New Antimitotic Agents with Activity in Multi-Drug-Resistant Cell Lines and in Vivo Efficacy in Murine Tumor Models

Suchergebnisse filtern